Slide

Innovation in Cancer Diagnosis and Surveillance

Detect Bladder Cancer early from a home urine sample

Have you been diagnosed with blood in the urine? GALEAS™ Bladder is a simple, sample-to-report urine test to detect the presence of bladder cancer. A negative result means no cystoscopy!!

Find out more

Slide

Highly Accurate

Gender Reveal Test - Now Available from 6 Weeks

Identify the biological sex of your baby with our highly accurate screening test from as early as 6 weeks into your pregnancy.

Find out more

Slide

Family DNA Tests

Only our DNA can accurately identify our biological relatives. Be it a father or mother of a child, our siblings, cousins, aunts/uncles and grandparents. All our DNA tests are confidential, discreet and conclusive. Processed in our UK laboratory with SAME day results available.

Find out more

Slide

HPV PCR Test for Cervical
Cancer Screening

Take control of your cervical health with this discreet self-collection kit in comfort of your own environment. Unique detection of 24 high-risk HPV types.

Find out more

Cancer Test Slide

Comprehensive Hereditary Cancer Test

If cancer runs in your family and you're worried about your risk of developing it then our clinically approved 31 gene hereditary cancer test is worth the investment.

Find out more

Allergy Test Slide

Allergy Solution - 295 allergens in a single test

The most comprehensive allergy test available. Identifies the root cause of your allergy, gives you a clear accurate diagnosis, and enables you to better manage and avoid unpleasant or life-threatening allergic reactions.

Find out more

PGX Test Slide

Pharmacogenomics Test

Almost 99% of us carry at least one genetic variant in our DNA that affects our response to commonly prescribed and over the counter drugs, resulting in unwanted side-effects or it not working effectively for you.

Find out more

Innovation is in our DNA

We are proud to be a leading reputable UK provider of genetic and molecular diagnostic tests delivering healthcare solutions that have a direct and meaningful impact on your wellbeing.

JULY 2024 – This month we bring you an update on the impact of Pharmacogenomic Testing for mental health medications.

The NHS spent £16 billion in 2022/23 on mental health services. Mental health conditions include depression, anxiety, bipolar disorder, and schizophrenia affect. More than 1 in 6 of us are reported to have experienced depression or anxiety just in the past week! Prescribing of antidepressants and antipsychotics has increased dramatically. However, these medications are associated with troublesome and often significant adverse drug reactions. Pharmacogenomics testing can make it possible to identify those patients most at risk of developing severe side effects and those who are unlikely to respond to treatment using their genetics.

Click here for more information on pharmacogenomic testing in mental health prescribing